Claudia Lanari Selected Research

Progesterone Receptors (Progesterone Receptor)

1/2022	Progesterone receptor isoform ratio dictates antiprogestin/progestin effects on breast cancer growth and metastases: A role for NDRG1.
12/2021	Progesterone receptors in normal breast development and breast cancer.
2/2020	Increased androgen receptor expression in estrogen receptor-positive/progesterone receptor-negative breast cancer.
10/2019	FGF2 induces breast cancer growth through ligand-independent activation and recruitment of ERα and PRBΔ4 isoform to MYC regulatory sequences.
7/2018	Biological and clinical impact of imbalanced progesterone receptor isoform ratios in breast cancer.
10/2017	Isoform specificity of progesterone receptor antibodies.
1/2017	Progesterone Receptor Isoform Ratio: A Breast Cancer Prognostic and Predictive Factor for Antiprogestin Responsiveness.
6/2015	Progestin and antiprogestin responsiveness in breast cancer is driven by the PRA/PRB ratio via AIB1 or SMRT recruitment to the CCND1 and MYC promoters.
5/2014	The effectiveness of nano chemotherapeutic particles combined with mifepristone depends on the PR isoform ratio in preclinical models of breast cancer.
1/2013	Targeting progesterone receptors in breast cancer.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Claudia Lanari Research Topics

Disease

48	Breast Neoplasms (Breast Cancer) 01/2022 - 01/2002
48	Neoplasms (Cancer) 01/2022 - 01/2002
29	Carcinoma (Carcinomatosis) 05/2020 - 05/2002
5	Neoplasm Metastasis (Metastasis) 01/2022 - 06/2005
3	Ductal Carcinoma 01/2017 - 05/2009
3	Breast Ductal Carcinoma 06/2009 - 05/2002
2	Adenocarcinoma 01/2020 - 05/2009
2	Carcinogenesis 07/2018 - 01/2007
2	Body Weight (Weight, Body) 04/2011 - 01/2005
1	Lymphatic Metastasis 01/2022
1	Polyploidy 05/2020
1	Infections 10/2018
1	Mucinous Adenocarcinoma (Mucinous Carcinoma) 02/2016
1	Urinary Bladder Neoplasms (Bladder Cancer) 01/2016

Drug/Important Bio-Agent (IBA)

36	Hormones (Hormone)IBA 01/2022 - 05/2002
31	Progesterone Receptors (Progesterone Receptor)IBA 01/2022 - 01/2002
25	Progestins (Progestagens)IBA 01/2022 - 01/2002
15	Medroxyprogesterone Acetate (Depo-Provera)FDA LinkGeneric 01/2022 - 05/2002
13	Protein Isoforms (Isoforms)IBA 01/2022 - 06/2003
11	Estrogens (Estrogen)FDA Link 10/2019 - 01/2002
10	Phenobarbital (Luminal)FDA Link 01/2022 - 08/2011
9	Mifepristone (RU 486)FDA Link 01/2021 - 01/2005
9	Estrogen Receptor alphaIBA 02/2020 - 01/2005
8	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 10/2019 - 12/2008
7	Estrogen ReceptorsIBA 02/2020 - 01/2007
6	Progesterone FDA LinkGeneric 05/2012 - 01/2002
5	Steroid Receptors (Steroid Receptor)IBA 01/2022 - 05/2009
4	Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA 01/2022 - 05/2011
4	Fulvestrant (Faslodex)FDA Link 05/2012 - 05/2003
3	LigandsIBA 01/2022 - 08/2011
3	Fibroblast Growth Factors (Fibroblast Growth Factor)IBA 01/2022 - 05/2011
3	progesterone receptor AIBA 10/2018 - 01/2007
3	Biological ProductsIBA 07/2018 - 05/2002
3	Biomarkers (Surrogate Marker)IBA 10/2017 - 01/2013
3	Proteins (Proteins, Gene)FDA Link 01/2017 - 06/2012
3	Estrogen Receptor Modulators (Antiestrogen)IBA 06/2012 - 05/2003
3	DNA (Deoxyribonucleic Acid)IBA 08/2011 - 04/2011
3	Tamoxifen FDA LinkGeneric 08/2009 - 05/2003
2	Glucocorticoid Receptors (Glucocorticoid Receptor)IBA 02/2020 - 01/2019
2	Androgen Receptors (Androgen Receptor)IBA 02/2020 - 01/2019
2	RNA (Ribonucleic Acid)IBA 01/2017 - 06/2003
2	CatecholaminesIBA 01/2017 - 07/2011
2	Cyclin D1IBA 01/2017 - 05/2012
2	Phosphotransferases (Kinase)IBA 05/2010 - 08/2009
1	NucleotidesIBA 01/2022
1	Amino Acids FDA Link 01/2022
1	Immunomodulating AgentsIBA 01/2021
1	Immune Checkpoint InhibitorsIBA 01/2021
1	AndrogensIBA 02/2020
1	Indicators and Reagents (Reagents)IBA 01/2019
1	Androgen Antagonists (Antiandrogens)IBA 01/2019
1	Progesterone CongenersIBA 07/2018
1	infigratinibIBA 01/2018
1	AntibodiesIBA 10/2017
1	Messenger RNA (mRNA)IBA 01/2017
1	human ERBB2 proteinIBA 01/2017
1	Isoproterenol (Isoprenaline)FDA LinkGeneric 01/2017
1	Focal Adhesion Protein-Tyrosine KinasesIBA 01/2017
1	Adrenergic Receptors (Adrenergic Receptor)IBA 01/2017
1	Epinephrine (Adrenaline)FDA LinkGeneric 01/2017
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 02/2016
1	MucinsIBA 02/2016
1	Transcription Factors (Transcription Factor)IBA 02/2016
1	Growth Factor ReceptorsIBA 02/2016
1	Coloring Agents (Dyes)IBA 09/2015
1	Ribosomal Protein S6IBA 09/2015
1	MTOR InhibitorsIBA 09/2015
1	Histone Deacetylase InhibitorsIBA 06/2015
1	Therapeutic UsesIBA 05/2014
1	130-nm albumin-bound paclitaxelIBA 05/2014
1	Liposomes (Liposome)IBA 05/2014
1	Pharmaceutical PreparationsIBA 05/2014
1	Doxorubicin (Adriamycin)FDA LinkGeneric 05/2014
1	Albumin-Bound Paclitaxel FDA Link 05/2014
1	Hexachlorobenzene (HCB)IBA 05/2013
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 06/2012
1	TOR Serine-Threonine KinasesIBA 03/2012
1	laminin 1IBA 03/2012
1	Keratin-8 (Keratin 8)IBA 03/2012
1	Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA 03/2012
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 03/2012
1	Adrenergic Agents (Adrenergic Drugs)IBA 07/2011
1	ThymidineIBA 07/2011
1	Yohimbine (Yocon)IBA 07/2011
1	Clonidine (ST 155)FDA LinkGeneric 07/2011
1	SteroidsIBA 05/2011
1	MethyltransferasesIBA 04/2011
1	Decitabine FDA Link 04/2011
1	IntegrinsIBA 10/2010
1	Apoptosis Inducing FactorIBA 10/2010
1	Caspase 9IBA 10/2010

Therapy/Procedure

15	Therapeutics 01/2022 - 06/2005
2	Drug Therapy (Chemotherapy) 01/2019 - 05/2014
2	Injections 01/2018 - 01/2013
2	Aftercare (After-Treatment) 01/2016 - 05/2002
2	Isogeneic Transplantation 02/2004 - 05/2002
1	Immunotherapy 01/2021
1	Hormone Replacement Therapy (Therapy, Hormone Replacement) 07/2018
1	Contraception (Birth Control) 05/2012
1	Lasers (Laser) 08/2011